RSC Pharmaceutics has reached an important milestone – its first Journal Impact Factor of 5.5. The work focusses on emerging technologies, including drug delivery, precision medicine and enhanced drug targeting, with potential to drive real change in health. Discover our metrics ➡ buff.ly/Os2BVlM
